The Future of Cancer Treatment: Will It Include Immunotherapy?

Cancer Cell

Volumn 22, Issue 1, 2012, Pages 7-8

  Bluestone, Jeffrey A ^a,b   Small, Eric J ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; IPILIMUMAB; MONOCLONAL ANTIBODY; PROGRAMMED DEATH 1 LIGAND 1; PROGRAMMED DEATH 1 LIGAND 1 MONOCLONAL ANTIBODY; PROGRAMMED DEATH 1 RECEPTOR; PROGRAMMED DEATH 1 RECEPTOR MONOCLONAL ANTIBODY; UNCLASSIFIED DRUG;

ANTIGEN EXPRESSION; CANCER IMMUNOTHERAPY; CELLULAR IMMUNITY; COLON CANCER; HUMAN; IMMUNOREGULATION; IMMUNOSURVEILLANCE; INNATE IMMUNITY; KIDNEY CANCER; LUNG CANCER; MELANOMA; NONHUMAN; PRIORITY JOURNAL; PROSTATE CANCER; SHORT SURVEY; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION; TUMOR CELL; TUMOR IMMUNITY; TUMOR REGRESSION;

EID: 84863740215     PISSN: 15356108     EISSN: 18783686     Source Type: Journal    
DOI: 10.1016/j.ccr.2012.06.009     Document Type: Short Survey

References (10)

1. Bour-Jordan H., Esensten J.H., Martinez-Llordella M., Penaranda C., Stumpf M., Bluestone J.A. Immunol. Rev. 2011, 241:180-205.
2. Brahmer J.R., Tykodi S.S., Chow L.Q., Hwu W.J., Topalian S.L., Hwu P., Drake C.G., Camacho L.H., Kauh J., Odunsi K., et al. N. Engl. J. Med. 2012, Published online June 2, 2012. 10.1056/NEJMoa1200694.
3. Egan J.G., Kuhns M.S., Allison J.P. Nat. Immunol. 2002, 3:611-618.
4. Hodi F.S., O'Day S.J., McDermott D.F., Weber R.W., Sosman J.A., Haanen J.B., Gonzalez R., Robert C., Schadendorf D., Hassel J.C., et al. N. Engl. J. Med. 2010, 363:711-723.
5. Jin H.T., Ahmed R., Okazaki T. Curr. Top. Microbiol. Immunol. 2011, 350:17-37.
6. Leach D.R., Krummel M.F., Allison J.P. Science 1996, 271:1734-1736.
7. Norde W.J., Hobo W., van der Voort R., Dolstra H. Blood 2012, Published online May 4, 2012. 10.1182/blood-2012-02-412510.
8. Topalian S.L., Hodi F.S., Brahmer J.R., Gettinger S.N., Smith D.C., McDermott D.F., Powderly J.D., Carvajal R.D., Sosman J.A., Atkins M.B., et al. N. Engl. J. Med. 2012, Published online June 2, 2012. 10.1056/NEJMoa1200690.
9. Walunas T.L., Lenschow D.J., Bakker C.Y., Linsley P.S., Freeman G.J., Green J.M., Thompson C.B., Bluestone J.A. Immunity 1994, 1:405-413.
10. Wolchok J.D., Hoos A., O'Day S., Weber J.S., Hamid O., Lebbé C., Maio M., Binder M., Bohnsack O., Nichol G., et al. Clin. Cancer Res. 2009, 15:7412-7420.